Testing effectiveness (Phase 2)Ended earlyNCT03124459
What this trial is testing
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Who this might be right for
Charcot-Marie-Tooth Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 63